Jonathan Poyer10 hours ago2 minResidential Mortgage Market - A Good Place to Invest? A Safe Place? Let's Take a Look
Jonathan Poyer1 day ago3 minBiotech Trading Around its 50-Day Moving Average - XBI Index +3.95% YTD. Novavax Spikes on Deal with Sanofi
Jonathan Poyer4 days ago1 min2024 Doubling the Number of Biotech Transactions from 2023. The Index Waits to Respond
Jonathan Poyer6 days ago2 minWhat to Think About Commercial Real Estate? How to Know When to Take A Look
Jonathan PoyerMay 83 minEarnings Season Continues with Lots of Beats - But Little Bounce to the Sector
Jonathan PoyerMay 22 minEarnings Season Highlights a Number of Beats but Not Enough to Raise the Index
Jonathan PoyerMay 13 minONO Pharmaceutical Acquires Deciphera in a Monster Deal - Earnings Season has Begun with Big Beats
Jonathan PoyerApr 242 minBiotech M&A Quiet Heading Into Earnings Season - Intra-Cellular (ITCI) Drug Hits in Clinical Trial and Creates Potential $1B+ Opportunity
Jonathan PoyerApr 231 minBiotech Capital Markets Activity - 130 Biotech Transactions YTD compared to Just 45 Last Year. $22B vs. $6B. Healthy Numbers but the Index Lags
Jonathan PoyerApr 232 minThere is (Much) More to AI Markets than NVIDIA - And That Dip Might Mean a Good Time to Buy
Jonathan PoyerApr 191 minVertex Announces Their Largest Deal Ever While AbbVie's News Around Neuroscience Drug Maker Makes More Waves
Jonathan PoyerApr 182 minVertex Pharmaceuticals Announces Largest Acquisition Ever - But Biotech Index Dips